|
WO2013112871A1
(en)
|
2012-01-27 |
2013-08-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Therapeutic il-13 polypeptides
|
|
US9738696B2
(en)
|
2012-08-09 |
2017-08-22 |
The Board Of Trustees Of The Leland Stanford Junior University |
Superkines and synthekines: repurposed cytokines with new and enhanced signaling activities
|
|
WO2014117121A1
(en)
|
2013-01-28 |
2014-07-31 |
St. Jude Children's Research Hospital, Inc. |
A chimeric receptor with nkg2d specificity for use in cell therapy against cancer and infectious disease
|
|
JP6936934B2
(ja)
|
2013-09-24 |
2021-09-22 |
メディシナ セラピューティクス インコーポレイテッド |
インターロイキン−４受容体結合融合タンパク質及びその使用
|
|
US10144770B2
(en)
|
2013-10-17 |
2018-12-04 |
National University Of Singapore |
Chimeric receptors and uses thereof in immune therapy
|
|
SG11201602979RA
(en)
*
|
2013-10-17 |
2016-05-30 |
Univ Singapore |
Chimeric receptor that triggers antibody-dependent cell cytotoxicity against multiple tumors
|
|
KR20210014210A
(ko)
|
2014-05-15 |
2021-02-08 |
내셔널 유니버시티 오브 싱가포르 |
변형된 천연 살해 세포 및 그의 용도
|
|
US20170151281A1
(en)
|
2015-02-19 |
2017-06-01 |
Batu Biologics, Inc. |
Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancer
|
|
MX2017014822A
(es)
|
2015-05-18 |
2018-04-30 |
Tcr2 Therapeutics Inc |
Composiciones y métodos para la reprogramación del tcr con proteínas de fusión.
|
|
WO2017161333A1
(en)
*
|
2016-03-18 |
2017-09-21 |
Unum Therapeutics |
Modified chimeric receptors and uses thereof in immune therapy
|
|
WO2017205254A1
(en)
*
|
2016-05-23 |
2017-11-30 |
Unum Therapeutics |
Immune cells expressing antibody-coupled t-cell receptor (actr) for use in inhibiting cancer cells expressing surface immunoglobulin
|
|
EP3487877A4
(en)
*
|
2016-07-19 |
2020-01-01 |
Unum Therapeutics Inc. |
USE OF THE ANTIBODY COUPLED T CELL RECEPTOR (ACTR) WITH MULTIPLE CANCER ANTIBODIES IN THE TREATMENT OF CANCER
|
|
CA3032498A1
(en)
|
2016-08-02 |
2018-02-08 |
TCR2 Therapeutics Inc. |
Compositions and methods for tcr reprogramming using fusion proteins
|
|
MX2019003899A
(es)
|
2016-10-07 |
2019-08-14 |
Tcr2 Therapeutics Inc |
Composiciones y metodos para reprogramacion de receptores de linfocitos t mediante el uso de proteinas de fusion.
|
|
EP3544996A2
(en)
|
2016-11-22 |
2019-10-02 |
TCR2 Therapeutics Inc. |
Compositions and methods for tcr reprogramming using fusion proteins
|
|
WO2018102795A2
(en)
|
2016-12-02 |
2018-06-07 |
University Of Southern California |
Synthetic immune receptors and methods of use thereof
|
|
WO2018112266A1
(en)
*
|
2016-12-14 |
2018-06-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Il-13 superkine: immune cell targeting constructs and methods of use thereof
|
|
WO2018132506A1
(en)
|
2017-01-10 |
2018-07-19 |
The General Hospital Corporation |
Chimeric antigen receptors based on alternative signal 1 domains
|
|
WO2018140960A1
(en)
*
|
2017-01-30 |
2018-08-02 |
Unum Therapeutics Inc. |
Improved antibody-coupled t cell receptor constructs and therapeutic uses thereof
|
|
CN110582298A
(zh)
*
|
2017-02-17 |
2019-12-17 |
优努姆治疗公司 |
抗bcma抗体和抗体偶联t细胞受体(actr)在癌症治疗和b细胞疾病中的联合使用
|
|
CN118599009A
(zh)
*
|
2017-03-16 |
2024-09-06 |
综合医院公司 |
靶向cd37的嵌合抗原受体
|
|
MX2019011526A
(es)
*
|
2017-03-27 |
2019-12-05 |
Hoffmann La Roche |
Receptores de union a antigeno mejorados.
|
|
CA3054104A1
(en)
*
|
2017-03-27 |
2018-10-04 |
F. Hoffmann-La Roche Ag |
Improved antigen binding receptor formats
|
|
CA3056439A1
(en)
|
2017-03-27 |
2018-10-04 |
National University Of Singapore |
Truncated nkg2d chimeric receptors and uses thereof in natural killer cell immunotherapy
|
|
AU2018245749A1
(en)
|
2017-03-27 |
2019-10-03 |
National University Of Singapore |
Stimulatory cell lines for ex vivo expansion and activation of natural killer cells
|
|
IL271012B2
(en)
|
2017-06-07 |
2023-12-01 |
Seagen Inc |
T cells with reduced surface fucosylation and methods for their preparation and use
|
|
CN111065409A
(zh)
*
|
2017-09-06 |
2020-04-24 |
弗雷德哈钦森癌症研究中心 |
Strep-tag特异性结合蛋白及其用途
|
|
AU2018347796B2
(en)
|
2017-10-10 |
2025-07-24 |
Medicenna Therapeutics, Inc. |
IL-4-fusion formulations for treatment of central nervous system (CNS) tumors
|
|
AU2018355462B9
(en)
*
|
2017-10-26 |
2022-04-28 |
Regents Of The University Of Minnesota |
Recombinant immune cells, methods of making, and methods of use
|
|
US11326156B2
(en)
*
|
2017-11-01 |
2022-05-10 |
Allogene Therapeutics, Inc. |
Modified caspase-9 polypeptides and methods of use thereof
|
|
JP2021502085A
(ja)
|
2017-11-09 |
2021-01-28 |
サンガモ セラピューティクス， インコーポレイテッド |
サイトカイン誘導性ｓｈ２含有タンパク質（ｃｉｓｈ）遺伝子の遺伝子改変
|
|
AU2018365080B2
(en)
|
2017-11-10 |
2025-07-24 |
Jura Bio, Inc. |
Major histocompatibility complex-based chimeric receptors and uses thereof for treating autoimmune diseases
|
|
EP3707160A1
(en)
|
2017-11-10 |
2020-09-16 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Chimeric antigen receptors targeting tumor antigens
|
|
BR112020012336A2
(pt)
*
|
2017-12-19 |
2021-03-30 |
Akouos, Inc. |
Administração de anticorpos terapêuticos mediada por aav para o ouvido interno
|
|
CN109970864A
(zh)
*
|
2017-12-28 |
2019-07-05 |
上海细胞治疗研究院 |
一种双向激活共刺激分子受体及其用途
|
|
JP2021508468A
(ja)
*
|
2017-12-29 |
2021-03-11 |
シティ・オブ・ホープＣｉｔｙ ｏｆ Ｈｏｐｅ |
メディトープ対応ｔ細胞
|
|
SG11202007156QA
(en)
|
2018-02-09 |
2020-08-28 |
Nat Univ Singapore |
Activating chimeric receptors and uses thereof in natural killer cell immunotherapy
|
|
JP7059390B2
(ja)
*
|
2018-03-19 |
2022-04-25 |
スワール ライフ サイエンス エービー |
Ａｄｃｃ及びａｄｃｐ活性の改善された定量化のためのシステム及び製品
|
|
SG11202008976YA
(en)
|
2018-04-02 |
2020-10-29 |
Nat Univ Singapore |
Neutralization of human cytokines with membrane-bound anti-cytokine non-signaling binders expressed in immune cells
|
|
IL321548A
(en)
|
2018-05-22 |
2025-08-01 |
Immunitybio Inc |
Recombinant NK cells expressing a chimeric antigen receptor (CAR) for epsilon-FC and uses thereof
|
|
JP2021529559A
(ja)
|
2018-07-03 |
2021-11-04 |
ソティオ，リミティド ライアビリティ カンパニー |
グルコース輸入を向上させるトランス代謝分子と組み合わせたキメラ受容体及びその治療的使用
|
|
SG11202101284UA
(en)
|
2018-08-14 |
2021-03-30 |
Sotio Llc |
Chimeric antigen receptor polypeptides in combination with trans metabolism molecules modulating krebs cycle and therapeutic uses thereof
|
|
US12486514B2
(en)
|
2018-08-29 |
2025-12-02 |
National University Of Singapore |
Method to specifically stimulate survival and expansion of genetically-modified immune cells
|
|
WO2020068702A1
(en)
*
|
2018-09-24 |
2020-04-02 |
Fred Hutchinson Cancer Research Center |
Chimeric receptor proteins and uses thereof
|
|
EP3876977A1
(en)
|
2018-11-06 |
2021-09-15 |
The Regents Of The University Of California |
Chimeric antigen receptors for phagocytosis
|
|
KR20210137085A
(ko)
|
2019-03-05 |
2021-11-17 |
엔카르타, 인크. |
Cd19 유도된 키메라 항원 수용체 및 면역 요법에서 이의 용도
|
|
WO2020188570A1
(en)
*
|
2019-03-19 |
2020-09-24 |
Ramot At Tel-Aviv University Ltd. |
T cell expressing an fc gamma receptor and methods of use thereof
|
|
CA3137397A1
(en)
|
2019-04-19 |
2020-10-22 |
Chugai Seiyaku Kabushiki Kaisha |
Chimeric receptor that recognizes engineered site in antibody
|
|
US11013764B2
(en)
|
2019-04-30 |
2021-05-25 |
Myeloid Therapeutics, Inc. |
Engineered phagocytic receptor compositions and methods of use thereof
|
|
CN110592014A
(zh)
*
|
2019-08-14 |
2019-12-20 |
广东美赛尔细胞生物科技有限公司 |
一种在nk细胞治疗中免辐照体外体内持续去除饲养细胞的方法
|
|
CN114981409A
(zh)
|
2019-09-03 |
2022-08-30 |
美洛德生物医药公司 |
用于基因组整合的方法和组合物
|
|
CN111944062B
(zh)
*
|
2019-12-09 |
2023-11-07 |
深圳市体内生物医药科技有限公司 |
一种识别Fc片段的嵌合抗原受体及其应用
|
|
US10980836B1
(en)
|
2019-12-11 |
2021-04-20 |
Myeloid Therapeutics, Inc. |
Therapeutic cell compositions and methods of manufacturing and use thereof
|
|
CN111100942B
(zh)
*
|
2019-12-31 |
2023-03-28 |
海南波莲水稻基因科技有限公司 |
与水稻光温敏核雄性不育表型相关的分子标记和应用
|
|
US20240261329A1
(en)
*
|
2020-02-13 |
2024-08-08 |
Sichuan University |
Chimeric antigen receptor and use thereof
|
|
EP3875478A1
(en)
*
|
2020-03-05 |
2021-09-08 |
Canvax Biotech, S.L. |
Novel non-immunogenic chimeric antigen receptors and uses thereof
|
|
EP4168438A4
(en)
|
2020-06-22 |
2024-07-10 |
Ramot at Tel-Aviv University Ltd. |
Multi subunit protein modules, cells expressing same and uses thereof
|
|
CN113583139A
(zh)
*
|
2020-07-06 |
2021-11-02 |
上海鑫湾生物科技有限公司 |
一种嵌合受体及其应用
|
|
IL300225A
(en)
|
2020-07-31 |
2023-03-01 |
Chugai Pharmaceutical Co Ltd |
A pharmaceutical composition including chimeric receptor expressing cells
|
|
CN111876382A
(zh)
*
|
2020-08-14 |
2020-11-03 |
上海星华生物医药科技有限公司 |
一种制备通用型免疫细胞的方法及其应用
|
|
US20230302132A1
(en)
*
|
2020-08-14 |
2023-09-28 |
Shanghai Xinghua Bio Pharmaceutical Science & Technology Co., Ltd |
Method for preparing universal immune cells and use thereof
|
|
EP4240367A4
(en)
|
2020-11-04 |
2024-10-16 |
Myeloid Therapeutics, Inc. |
MODIFIED CHIMERIC FUSION PROTEIN COMPOSITIONS AND METHODS OF USE THEREOF
|
|
AU2021391433A1
(en)
|
2020-12-01 |
2023-06-22 |
Akouos, Inc. |
Anti-vegf antibody constructs and related methods for treating vestibular schwannoma associated symptoms
|
|
CN116964082A
(zh)
*
|
2020-12-22 |
2023-10-27 |
免疫生物公司 |
Fc受体CAR构建体和细胞
|
|
WO2022150379A1
(en)
*
|
2021-01-08 |
2022-07-14 |
Regents Of The University Of Minnesota |
Nk cell engager molecules and methods of use
|
|
CA3212398A1
(en)
|
2021-03-17 |
2022-09-22 |
Daniel Getts |
Engineered chimeric fusion protein compositions and methods of use thereof
|
|
CA3218780A1
(en)
|
2021-05-11 |
2022-11-17 |
Daniel Getts |
Methods and compositions for genomic integration
|
|
JP2024536859A
(ja)
|
2021-09-27 |
2024-10-08 |
ソティオ バイオテック インコーポレイティド |
解糖経路からグルコース代謝産物を再誘導するトランス代謝分子と組み合わせたキメラ受容体ポリペプチド及びその治療的使用
|
|
WO2023091909A1
(en)
|
2021-11-16 |
2023-05-25 |
Sotio Biotech Inc. |
Treatment of myxoid/round cell liposarcoma patients
|
|
CN116715766B
(zh)
*
|
2022-03-30 |
2025-01-14 |
河北森朗生物科技有限公司 |
靶向cd7的纳米抗体及其相关产品和医药用途
|
|
WO2024040207A1
(en)
|
2022-08-19 |
2024-02-22 |
Sotio Biotech Inc. |
Genetically engineered natural killer (nk) cells with chimeric receptor polypeptides in combination with trans metabolism molecules and therapeutic uses thereof
|
|
EP4572787A1
(en)
|
2022-08-19 |
2025-06-25 |
SOTIO Biotech Inc. |
Genetically engineered immune cells with chimeric receptor polypeptides in combination with multiple trans metabolism molecules and therapeutic uses thereof
|
|
WO2024102954A1
(en)
*
|
2022-11-10 |
2024-05-16 |
Massachusetts Institute Of Technology |
Activation induced clipping system (aics)
|
|
EP4694916A1
(en)
|
2023-04-14 |
2026-02-18 |
SOTIO Biotech Inc. |
Engineered immune cells for treating cancer in combination with il-2/il-15 receptor ?? agonists
|
|
WO2024215987A1
(en)
|
2023-04-14 |
2024-10-17 |
Sotio Biotech Inc. |
IMMUNE CELLS FOR TREATING CANCER IN COMBINATION WITH IL-15/IL-15Rα CONJUGATES
|
|
KR20260024373A
(ko)
*
|
2023-05-05 |
2026-02-20 |
더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 |
다중-수용체 자연 살해 세포
|
|
WO2025103439A1
(zh)
*
|
2023-11-16 |
2025-05-22 |
广州瑞风生物科技有限公司 |
一种嵌合抗原受体及其应用
|
|
KR102764613B1
(ko)
*
|
2024-03-28 |
2025-02-12 |
한양대학교 에리카산학협력단 |
NaPi2b 특이적 CAR-T를 포함하는 난소암 치료용 약학 조성물
|
|
WO2025235862A1
(en)
*
|
2024-05-10 |
2025-11-13 |
Inndura Therapeutics Inc. |
A modified immune cell receptor comprising a target-binding domain and the extracellular domain of cd16a
|